The company specializes in omnichannel marketing of pharmaceutical brands through online and digital channels. The company uses dynamic data analysis, automated target audience communication, and its own IT platforms.
Investments
Date of transaction
Volume of investments
Round
Investors
December 2021
$10 166 831
A
Elbrus Capital